Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-10T08:57:40.582Z Has data issue: false hasContentIssue false
  • English
  • Français

Observations on the Psychotogenic Effect of N-N Diethyltryptamine, a New Tryptamine Derivative

Published online by Cambridge University Press:  08 February 2018

Z. Böszörményi ,
P. Dér  and
T. Nagy
Z. Böszörményi
Affiliation:
From the Central State Institute of Nervous and Mental Diseases, Budapest
P. Dér
Affiliation:
From the Central State Institute of Nervous and Mental Diseases, Budapest
T. Nagy
Affiliation:
From the Central State Institute of Nervous and Mental Diseases, Budapest
Get access Rights & Permissions [Opens in a new window]

Extract

Since Evarts, Fabing and Marrazzi reported on bufotenine and Szára on N-N dimethyltryptamine (DMT) the tryptamine derivatives have been arousing increased interest. A team of the above Institute was the first to test DMT and N-N diethyltryptamine (DET) in man. These compounds were synthesized by Szára, by the method of Speeter and Anthony. DET was then synthesized again and analysed pharmacologically by Borsi and Lénárt.

Type
Original Articles
Information
Journal of Mental Science , Volume 105 , Issue 438 , January 1959 , pp. 171 - 181
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arnold, O. H., Wien. Z. Nervenheilk., 1953, 7, 188.Google Scholar
Idem , and Hoffmann, G., Wien. Z. Nervenheilk., 1957, 13, 438.CrossRefGoogle Scholar
Baruk, H. et al., Ann. méd.-psychol., 1958, 116, 115.Google Scholar
Becker, A. M., Wien. Z. Nervenheilk., 1949, 2, 402.Google Scholar
de Boor, W., Pharmakopsychologie und Psychopathologie, 1956. Berlin: Springer.Google Scholar
Borsi, E., personal communication.Google Scholar
Böszörményi, Z., and Szára, I., J. Ment. Sci., 1958, 104, 445.Google Scholar
Costa, E., Rinaldi, F., and Himwich, H. E., Psychotropic Drugs (Ed.: Garattini-Ghetti), 1957. Amsterdam: Elsevier, p. 21.Google Scholar
Denber, H. C. B., Psychotropic Drugs (Ed.: Garattini-Ghetti, ), 1957. Amsterdam: Elsevier, p. 26.Google Scholar
Evarts, E. V., Arch. Neurol. Psychiat., 1956, 75, 49.Google Scholar
Fabing, H. D., Amer. J. Psychiat., 1956, 113, 409.CrossRefGoogle Scholar
Idem , and Hawkins, , —. Science, 1956, 123, 886.Google Scholar
Kajtor, F., personal communication.Google Scholar
Marrazzi, A. S., and Hart, E. R., J. Nerv. Ment. Dis., 1955, 122, 483.Google Scholar
Idem, Psychotropic Drugs (Ed.: Garattini-Ghetti, ), 1957. Amsterdam: Elsevier, P. 283.Google Scholar
Purpura, D. P., Arch. Neurol. Psychiat., 1956, 75, 122.CrossRefGoogle Scholar
Rinaldi, F., and Himwich, H. È., J. Nerv. Ment. Dis., 1955, 122, 424.CrossRefGoogle Scholar
Sai-Halász, A., Brunecker, Gy., and Szára, I., Psychait. Neurol., Basel, 1958, 135, 285.Google Scholar
Savage, C., and Cholden, L., J. clin. exper. Psychopath., 1956, 17, 420.Google Scholar
Szára, St., Experientia, 1956, 12, 441.CrossRefGoogle Scholar
Idem, Psychotropic Drugs (Ed.: Garattini-Ghetti, ), 1957. Amsterdam: Elsevier, 1957, p. 460. p. 460.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.